News

4Moving Biotech Secures €7.6M France 2030 Grant for Pioneering First-In-Class Disease-Modifying Osteoarthritis Drug

Clinical Trial Press Release

Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis

4Moving Biotech at ORS Annual Congress

February 4, 2025

4Moving Biotech’s Participation at ACR Conference 2024

November 7, 2024

Gala de la Fondation Arthritis 2024

November 4, 2024

World Arthritis Day

October 12, 2024

End of content

Get In Touch ×